Ligustrazine Inhibits the Migration and Invasion of Renal Cell Carcinoma
Ligustrazine is a Chinese herb (Chuanxiong) approved for use as a medical drug in China. Recent evidence suggests that ligustrazine has promising antitumor properties. Our preliminary results showed that ligustrazine could inhibit the growth of human renal cell carcinoma (RCC) cell lines. However,...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Codon Publications
2023-01-01
|
Series: | Journal of Kidney Cancer and VHL |
Subjects: | |
Online Access: | https://mail.jkcvhl.com/~jkcvhlco/index.php/jkcvhl/article/view/232 |